Article
Cardiac & Cardiovascular Systems
Gabriel Gimenez-Perez, Clara Vinals, Manel Mata-Cases, Bogdan Vlacho, Jordi Real, Josep Franch-Nadal, Emilio Ortega, Didac Mauricio
Summary: This study investigates the characteristics of first-ever cardiovascular events in patients with type 1 diabetes and reveals differences according to age and sex. The most frequent event overall is peripheral vascular disease, while heart failure is more common in women and in older age groups. Higher HbA1c levels are associated with incident CVD only in patients younger than 55/60 years.
CARDIOVASCULAR DIABETOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Joao Sergio Neves, Marta Borges-Canha, Francisco Vasques-Novoa, Jennifer B. Green, Lawrence A. Leiter, Christopher B. Granger, Davide Carvalho, Adelino Leite-Moreira, Adrian F. Hernandez, Stefano Del Prato, John J. V. McMurray, Joao Pedro Ferreira Md
Summary: This study aimed to evaluate the effects of GLP-1 receptor agonists (GLP-1 RAs) on cardiovascular outcomes in patients with type 2 diabetes (T2D) treated with or without SGLT2 inhibitors. The results showed that GLP-1 RAs reduced cardiovascular events independently of SGLT2 inhibitor use, suggesting that the combination of GLP-1 RAs with SGLT2 inhibitors may further reduce cardiovascular risk.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Multidisciplinary Sciences
Eiichiro Kanda, Atsushi Suzuki, Masaki Makino, Hiroo Tsubota, Satomi Kanemata, Koichi Shirakawa, Toshitaka Yajima
Summary: A novel machine learning model was developed to predict the risk of developing CKD/HF in early-stage T2DM patients, showing good predictive performance in external validation. Early diagnosis and intervention based on ML models may improve the prognosis of high-risk patients.
SCIENTIFIC REPORTS
(2022)
Article
Pharmacology & Pharmacy
Fu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, Chih-Cheng Hsu, Chii-Min Hwu
Summary: In patients with both type 2 diabetes mellitus and chronic obstructive pulmonary disease, the use of metformin is associated with a lower risk of cardiovascular disease, and the longer the duration of metformin use, the lower the risk. Further prospective studies are needed to verify these findings.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Endocrinology & Metabolism
Raija Lithovius, Anni A. Antikainen, Stefan Mutter, Erkka Valo, Carol Forsblom, Valma Harjutsalo, Niina Sandholm, Per-Henrik Groop
Summary: This study explores the use of a genetic risk score (GRS) for coronary artery disease (CAD) risk prediction in individuals with type 1 diabetes. The GRS showed similar predictive performance to established clinical markers and was more effective in younger individuals.
Article
Cardiac & Cardiovascular Systems
Arnaud D. Kaze, Sebhat Erqou, Prasanna Santhanam, Alain G. Bertoni, Rexford S. Ahima, Gregg C. Fonarow, Justin B. Echouffo-Tcheugui
Summary: This study found that greater variability in adiposity indices in individuals with type 2 diabetes was associated with a higher risk of incident heart failure, independently of traditional risk factors and baseline adiposity levels.
CARDIOVASCULAR DIABETOLOGY
(2022)
Article
Multidisciplinary Sciences
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo J. Wagner, Attila J. Szabo, Andrea Fekete, Dora B. Balogh
Summary: This study investigated the role of SGLT2 inhibitor dapagliflozin (DAPA) in preventing cardiovascular complications induced by diabetes. The results showed that DAPA reduced blood glucose levels, mitigated aortic intima-media thickening, and prevented cardiac hypertrophy, myocardial damage, cardiac inflammation, and fibrosis. These findings support the preventive and protective role of SGLT2 inhibitors in diabetes-associated cardiovascular disease.
Article
Endocrinology & Metabolism
Yilu Lin, Hui Shao, Lizheng Shi, Amanda H. Anderson, Vivian Fonseca
Summary: This study aimed to predict the risk of heart failure among patients with diabetes using a scoring algorithm. The model showed good discrimination and calibration in predicting the risk of heart failure, and age, healthcare utilization, and cardiovascular disease-related variables were found to be the strongest predictors. The model can be easily applied in clinical practice for risk stratification.
DIABETES OBESITY & METABOLISM
(2022)
Article
Endocrinology & Metabolism
Aila J. Ahola, Valma Harjutsalo, Carol Forsblom, Francois Pouwer, Per-Henrik Groop
Summary: The study found that diagnosed depression and antidepressant purchases are associated with the progression of diabetic nephropathy in type 1 diabetes patients, however, symptoms of depression themselves did not show a significant association with progression. Further research is needed to determine if successful treatment of depression can reduce the risk.
Article
Endocrinology & Metabolism
Hongyan Liu, Vikas S. Sridhar, Jacinthe Boulet, Atit Dharia, Abid Khan, Patrick R. Lawler, David Z. Cherney
Summary: SGLT2 inhibitors have emerged as an effective treatment for cardiovascular and renal diseases associated with T2D, with diverse benefits. Research is underway to elucidate the mechanisms underlying the effects of SGLT2 inhibitors.
METABOLISM-CLINICAL AND EXPERIMENTAL
(2022)
Review
Endocrinology & Metabolism
Ana Maria Stanton, Muthiah Vaduganathan, Lee-Shing Chang, Alexander Turchin, James L. Januzzi, Vanita R. Aroda
Summary: DbCM is a common asymptomatic form of HF that represents a transitional phase before symptomatic HF onset, involving multiple pathogenic mechanisms such as hyperglycemia, insulin resistance, and oxidative stress. Early recognition and intervention of DbCM can help reduce the burden of global HF complications.
CURRENT DIABETES REPORTS
(2021)
Article
Endocrinology & Metabolism
Ying He, Jincheng Feng, Bo Zhang, Qiong Wu, Yongjie Zhou, Diao He, Daofeng Zheng, Jiayin Yang
Summary: This study utilized Mendelian randomization (MR) analysis to explore the causality between serum uric acid (SUA) levels and the risk of cardiovascular disease (CVD) in individuals with type 2 diabetes (T2D). The results did not find supporting evidence for a causal association between SUA levels and the risk of heart failure.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Medicine, General & Internal
Jose Antonio Gimeno-Orna, Luis Rodriguez-Padial, Manuel Anguita-Sanchez, Vivencio Barrios, Javier Muniz, Antonio Perez
Summary: The study revealed that age, blood pressure, hemoglobin levels, obstructive sleep apnea, hepatic steatosis, severity of atherosclerotic involvement, and KDIGO risk classification were independent predictors of heart failure in patients with type 2 diabetes.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Mariam Elmegaard Malik, Charlotte Andersson, Paul Blanche, Maria D'Souza, Christian Madelaire, Bochra Zareini, Morten Lamberts, Soren Lund Kristensen, Naveed Sattar, John McMurray, Lars Kober, Christian Torp-Pedersen, Gunnar Gislason, Morten Schou
Summary: This study estimated the risk of different cardiovascular events in patients with T2D and newly established cardiovascular disease, and found that different cardiovascular phenotypes can help predict the pattern of future cardiovascular events.
CLINICAL RESEARCH IN CARDIOLOGY
(2022)
Article
Endocrinology & Metabolism
Tingting Geng, Jun-Xiang Chen, Yan-Feng Zhou, Qi Lu, Zhenzhen Wan, Liegang Liu, An Pan, Gang Liu
Summary: Based on data from the UK Biobank study, researchers found a significant association between proton pump inhibitor (PPI) use and increased risks of cardiovascular disease events and all-cause mortality in patients with type 2 diabetes. The study suggests that monitoring of adverse cardiovascular events and careful consideration of the benefits and risks of PPI use should be implemented in patients with type 2 diabetes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2023)
Article
Nutrition & Dietetics
Isabel Cornejo-Pareja, Isabel M. Vegas-Aguilar, Jose Manuel Garcia-Almeida, Diego Bellido-Guerrero, Antonio Talluri, Henry Lukaski, Francisco J. Tinahones
Summary: The study found that non-surviving COVID-19 patients had significantly lower PhA and SPhA values, as well as increased hydration. In COVID-19 patients, low PhA (<3.95 degrees) was identified as a significant predictor of mortality risk.
CLINICAL NUTRITION
(2022)
Article
Respiratory System
Olga Mediano, Nicolas Gonzalez Mangado, Josep M. Montserrat, M. Luz Alonso-Alvarez, Isaac Almendros, Alberto Alonso-Fernandez, Ferran Barbe, Eduardo Borsini, Candelaria Caballero-Eraso, Irene Cano-Pumarega, Felix de Carlos Villafranca, Carmen Carmona-Bernal, Jose Luis Carrillo Alduenda, Eusebi Chiner, Jose Aurelio Cordero Guevara, Luis de Manuel, Joaquin Duran-Cantolla, Ramon Farre, Carlos Franceschini, Carles Gaig, Pedro Garcia Ramos, Francisco Garcia-Rio, Onintza Garmendia, Teresa Gomez Garcia, Silvia Gonzalez Pondal, M. Blanca Hoyo Rodrigo, Albert Lecube, Juan Antonio Madrid, Lourdes Maniegas Lozano, Jose Luis Martinez Carrasco, Juan Fernando Masa, Maria Jose Masdeu Margalef, Merce Mayos Perez, Enrique Mirabet Lis, Carmen Monasterio, Nieves Navarro Soriano, Erika Olea de la Fuente, Guillermo Plaza, Francisco Javier Puertas Cuesta, Claudio Rabec, Pilar Resano, David Rigau, Alejandra Roncero, Concepcion Ruiz, Neus Salord, Adriana Saltijeral, Gabriel Sampol Rubio, M. Angeles Sanchez Quiroga, Oscar Sans Capdevila, Carlos Teixeira, Francisco Tinahones Madueno, Sonia Maria Togeiro, Maria Fernanda Troncoso Acevedo, Leslie Katherine Vargas Ramirez, Joao Winck, Nerea Zabala Urionaguena, Carlos Egea
Summary: The aim of this international consensus document is to provide guidelines for healthcare professionals in the care of adult patients with obstructive sleep apnea based on a critical analysis of the latest literature. The document was developed by an expert working group consisting of scientific societies, specialists, and a methodology expert, and includes systematic literature searches for each section. The document does not cover pediatric patients or the management of patients receiving chronic non-invasive mechanical ventilation.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Article
Biochemistry & Molecular Biology
Andrea G. Izquierdo, Hatim Boughanem, Angel Diaz-Lagares, Isabel Arranz-Salas, Manel Esteller, Francisco J. Tinahones, Felipe F. Casanueva, Manuel Macias-Gonzalez, Ana B. Crujeiras
Summary: The study identified specific epigenetic marks in visceral adipose tissue associated with colorectal cancer, potentially providing useful tools for prediction and personalized treatment of CRC.
Article
Urology & Nephrology
Hiddo J. L. Heerspink, David Cherney, Douwe Postmus, Bergur Stefansson, Glenn M. Chertow, Jamie P. Dwyer, Tom Greene, Mikhail Kosiborod, Anna Maria Langkilde, John J. McMurray, Ricardo Correa-Rotter, Peter Rossing, C. David Sjostrom, Robert D. Toto, David C. Wheeler
Summary: This analysis of DAPA-CKD found that dapagliflozin can reduce the risk of abrupt declines in kidney function in patients with CKD and substantial albuminuria.
KIDNEY INTERNATIONAL
(2022)
Letter
Medicine, General & Internal
Jose Antonio Lopez Medina, Victor Jose Simon Frapolli, Francisco Jose Tinahones Madueno
Letter
Medicine, General & Internal
Jose Ignacio Martinez-Montoro, Ana Maria Gomez-Perez, Elena Gallego, Jorge Garcia-Aleman, Arantzazu Sebastian-Ochoa, Miguel Damas-Fuentes, Isabel Mancha-Doblas, Francisco J. Tinahones
ARCHIVES OF MEDICAL SCIENCE
(2022)
Article
Nutrition & Dietetics
Paula M. Lorenzo, Ignacio Sajoux, Andrea G. Izquierdo, Diego Gomez-Arbelaez, M. Angeles Zulet, Itziar Abete, Ana I. Castro, Javier Baltar, Maria P. Portillo, Francisco J. Tinahones, J. Alfredo Martinez, Felipe F. Casanueva, Ana B. Crujeiras
Summary: This study aimed to evaluate the effect of a very-low-calorie ketogenic diet (VLCKD) compared to a standard, balanced hypocaloric diet (LCD) or bariatric surgery (BS) on the inflammatory and oxidative stress profile in patients with obesity. The results showed that VLCKD induced more notable changes in cytokines and lipid peroxides, especially during the ketosis phase of the intervention.
CLINICAL NUTRITION
(2022)
Article
Medicine, General & Internal
Teresa Maria Linares-Pineda, Hatim Boughanem, Carolina Gutierrez-Repiso, Manuel Macias-Gonzalez, Eduardo Andres-Leon, Gemma Rojo-Martinez, Sergio Valdes, Francisco J. Tinahones, Sonsoles Morcillo
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2022)
Article
Food Science & Technology
Jiaqi Ni, Stephanie K. Nishi, Nancy Babio, Miguel A. Martinez-Gonzalez, Dolores Corella, Olga Castaner, J. Alfredo Martinez, Angel M. Alonso-Gomez, Enrique Gomez-Gracia, Jesus Vioque, Dora Romaguera, Jose Lopez-Miranda, Ramon Estruch, Francisco J. Tinahones, Jose Lapetra, J. Luis Serra-Majem, Aurora Bueno-Cavanillas, Josep A. Tur, Vicente Martin-Sanchez, Xavier Pinto, Jose J. Gaforio, Ana Barabash Bustelo, Josep Vidal, Clotilde Vazquez, Lidia Daimiel, Emili Ros, Estefania Toledo, Oscar Coltell, Carlos Gomez-Martinez, Maria Dolores Zomeno, Carolina Donat-Vargas, Leire Goicolea-Guemez, Cristina Bouzas, Manoli Garcia-de-la-Hera, Alice Chaplin, Antonio Garcia-Rios, Rosa Casas, Isabel Cornejo-Pareja, Jose Manuel Santos-Lozano, Teresa Rognoni, Carmen Saiz, Indira Paz-Ganiel, Mireia Malcampo, Almudena Sanchez-Villegas, Itziar Salaverria-Lete, Ana Garcia-Arellano, Helmut Schroeder, Jordi Salas-Salvado
Summary: This study found that older adults with higher consumption of total milk and whole-fat milk are more likely to experience a decline in cognitive function, while consumption of low-fat milk, yogurt, cheese or fermented dairy had no significant impact.
MOLECULAR NUTRITION & FOOD RESEARCH
(2022)
Review
Endocrinology & Metabolism
Jose Ignacio Martinez-Montoro, Enrique Morales, Isabel Cornejo-Pareja, Francisco J. Tinahones, Jose Carlos Fernandez-Garcia
Summary: Obesity-related glomerulopathy (ORG) is a silent comorbidity associated with serious health consequences. Despite the pathogenic mechanisms not fully understood, factors such as glomerular hemodynamic changes and RAAS overactivation are believed to play a major role. Early diagnosis and intervention are crucial for improving the prognosis of ORG.
Article
Endocrinology & Metabolism
Yuan-Di Halvorsen, John Paul Lock, Juan P. Frias, Francisco Jose Tinahones, Dominik Dahl, Annie L. Conery, Mason W. Freeman
Summary: This study compared the effects of bexagliflozin tablets and glimepiride on the treatment of patients with type 2 diabetes. It was found that bexagliflozin tablets were noninferior to glimepiride in lowering HbA1c levels, and were superior in reducing body mass and systolic blood pressure. Additionally, bexagliflozin tablets were associated with fewer hypoglycemic events and had a favorable effect on estimated glomerular filtration rate (eGFR).
DIABETES OBESITY & METABOLISM
(2023)
Review
Nutrition & Dietetics
Hatim Boughanem, Pallavi Kompella, Francisco J. Tinahones, Manuel Macias-Gonzalez
Summary: Gene expression can be regulated by epigenomic modifications such as DNA methylation, histone modification, and chromosome remodeling. Vitamins, as natural bioactive compounds, have been found to modify epigenetic patterns and potentially impact the risk of cancer, including colorectal cancer (CRC). This review examines the relationship between vitamins and CRC risk through epidemiological and observational studies and discusses the potential of using vitamins as epigenetic modifiers for CRC treatment. Although more studies with better designs are needed, understanding the molecular mechanisms of vitamin-mediated epigenetic regulation can help identify effective therapeutic targets for CRC prevention and treatment.
Article
Psychology, Clinical
Sangeetha Shyam, Carlos Gomez-Martinez, Indira Paz-Graniel, Jose J. Gaforio, Miguel Angel Martinez-Gonzalez, Dolores Corella, Montserrat Fito, J. Alfredo Martinez, Angel M. Alonso-Gomez, Julia Warnberg, Jesus Vioque, Dora Romaguera, Jose Lopez-Miranda, Ramon Estruch, Francisco J. Tinahones, Jose Manuel Santos-Lozano, J. Luis Serra-Majem, Aurora Bueno-Cavanillas, Josep A. Tur, Vicente Martin Sanchez, Xavier Pinto, Maria Ramos, Josep Vidal, Maria Mar Alcarria, Lidia Daimiel, Emilio Ros, Fernando Fernandez-Aranda, Stephanie K. Nishi, Oscar Garcia Regata, Estefania Toledo, Jose V. Sorli, Olga Castaner, Antonio Garcia-Rios, Rafael Valls-Enguix, Napoleon Perez-Farinos, M. Angeles Zulet, Elena Rayo-Gago, Rosa Casas, Mario Rivera-Izquierdo, Lucas Tojal-Sierra, Miguel Damas-Fuentes, Pilar Buil-Cosiales, Rebeca Fernandez-Carrion, Albert Goday, Patricia J. Pena-Orihuela, Laura Compan-Gabucio, Javier Diez-Espino, Susanna Tello, Ana Gonzalez-Pinto, Victor de la O, Miguel Delgado-Rodriguez, Nancy Babio, Jordi Salas-Salvado
Summary: COVID-19 is associated with long-term depression risk in older adults, especially in women. Long-term evaluations of the impact of COVID-19 on mental health and preventive public health initiatives are necessary for older adults.
PSYCHOLOGICAL MEDICINE
(2023)
Article
Nutrition & Dietetics
Carolina Donat-Vargas, Victor Mico, Rodrigo San-Cristobal, Miguel Angel Martinez-Gonzalez, Jordi Salas-Salvado, Dolores Corella, Montserrat Fito, Angel Maria Alonso-Gomez, Julia Waernberg, Jesus Vioque, Dora Romaguera, Jose Lopez-Miranda, Ramon Estruch, Miguel Damas-Fuentes, Jose Lapetra, Luis Serra-Majem, Aurora Bueno-Cavanillas, Josep Antoni Tur, Sergio Cinza-Sanjurjo, Xavier Pinto, Miguel Delgado-Rodriguez, Pilar Matia-Martin, Josep Vidal, Claudia Causso, Emilio Ros, Estefania Toledo, Josep Maria Manzanares, Carolina Ortega-Azorin, Olga Castaner, Patricia Judith Pena-Orihuela, Juan Manuel Zazo, Carlos Munoz Bravo, Diego Martinez-Urbistondo, Alice Chaplin, Rosa Casas, Naomi Cano Ibanez, Lucas Tojal-Sierra, Ana Maria Gomez-Perez, Elena Pascual Roquet-Jalmar, Cristina Mestre, Rocio Barragan, Helmut Schroder, Antonio Garcia-Rios, Inmaculada Candela Garcia, Miguel Ruiz-Canela, Nancy Babio, Mireia Malcampo, Lidia Daimiel, Alfredo Martinez
Summary: Anemia and lower levels of anemia markers are associated with inferior cognitive function, worse executive function, and poorer physical component of quality of life. These effects are particularly pronounced in individuals with diabetes. Dietary iron intake does not influence these outcomes.
Article
Endocrinology & Metabolism
Beatriz Fernandez-Medina, Isabel Vegas-Aguilar, Jose Manuel Garcia-Almeida, Isabel Sevilla-Garcia, Carmen Hernandez-Garcia, Francisco Jose Tinahones-Madueno
Summary: Patients with gastroenteropancreatic neuroendocrine tumors (GEPNET) show a moderate affection of nutritional status compared to the general population, and morfo-functional evaluation provides precise knowledge about nutritional status.
ENDOCRINOLOGIA DIABETES Y NUTRICION
(2022)